Related Experiment Video
Updated: Feb 6, 2026
Protein Modifications: Protein Kinases and Phosphatases
Soluble CD40L and cardiovascular risk in women
1Leducq Center for Cardiovascular Research, Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. uschoenbeck@rics.bwh.harvard.edu
Insights
Elevated soluble CD40L (sCD40L) levels in healthy women may predict future cardiovascular events like heart attack or stroke. This finding suggests sCD40L could be an early biomarker for vascular risk.
Area of Science:
- Cardiovascular disease research
- Immunology and atherosclerosis
Background:
- The CD40/CD40L signaling pathway is implicated in promoting atherosclerosis.
- Elevated soluble CD40L (sCD40L) is observed in patients with unstable angina.
Purpose of the Study:
- To investigate if elevated circulating sCD40L levels precede the onset of acute cardiovascular symptoms.
Main Methods:
- Prospective, nested case-control study involving healthy middle-aged women.
- Measurement of baseline plasma sCD40L concentrations.
- 4-year follow-up to identify cardiovascular events (myocardial infarction, stroke, cardiovascular death).
Main Results:
- Mean sCD40L concentrations were significantly higher in women who later experienced cardiovascular events compared to controls.
- Women with sCD40L above the 95th percentile had a 3.3-fold increased risk of future cardiovascular events.
- This association remained significant after adjusting for traditional cardiovascular risk factors.
Conclusions:
- High plasma sCD40L concentrations are associated with increased vascular risk in apparently healthy women.
- sCD40L may serve as a potential predictive biomarker for cardiovascular events.
Background:
The immune-signaling dyad CD40/CD40L promotes atherogenesis, and patients with unstable angina have elevated plasma levels of soluble CD40L (sCD40L) and membrane-bound CD40L. It is unknown, however, whether elevations of circulating sCD40L precede the onset of acute cardiovascular symptoms.
Methods And Results:
In a prospective, nested case-control evaluation of healthy middle-aged women, mean concentrations of sCD40L at baseline were significantly higher among 130 participants who subsequently developed myocardial infarction, stroke, or cardiovascular death (cases), compared with 130 age- and smoking-matched women who remained free of cardiovascular disease (controls) during a 4-year follow-up (2.86 ng/mL for cases versus 2.09 ng/mL for controls; P=0.02). Women with concentrations above the 95th percentile of the control distribution (>3.71 ng/mL) had a significantly increased relative risk (RR) of developing future cardiovascular events (RR, 3.3; 95% CI, 1.2 to 8.6; P=0.01) that remained after adjustment for usual cardiovascular risk factors (multivariate RR, 2.8; 95% CI, 0.9 to 8.0; P=0.05).
Conclusions:
High plasma concentrations of sCD40L may be associated with increased vascular risk in apparently healthy women.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Co-activators and Co-repressors
Activation Energy
Activation and Inactivation of G Proteins